Google’s parent company, Alphabet, has applied for federal permission to release up to 32 million laboratory-bred mosquitoes across California and Florida as part of an ambitious effort to combat mosquito-borne diseases using advanced biotechnology and artificial intelligence.
The proposal, currently under review by the U.S. Environmental Protection Agency (EPA), forms part of Alphabet’s Project Debug initiative, a program designed to reduce populations of disease-carrying mosquitoes without relying heavily on chemical pesticides.
If approved, the company would release up to 16 million specially treated mosquitoes annually in each state over a two-year period. The initiative targets mosquito species responsible for spreading serious illnesses including dengue fever, West Nile virus, Zika virus, and St. Louis encephalitis.
At the center of the proposal is a scientific approach known as the Wolbachia method.
Rather than releasing biting mosquitoes, Alphabet plans to release only male mosquitoes that have been infected with Wolbachia, a naturally occurring bacterium found in many insect species.
Because male mosquitoes do not bite humans, they do not directly transmit disease or pose a threat to people.
When the treated males mate with wild female mosquitoes, the presence of Wolbachia creates a biological incompatibility that prevents viable offspring from developing. As a result, the eggs fail to hatch, gradually reducing mosquito populations over time.
Scientists often describe the technique as a form of biological birth control because it suppresses pest populations without introducing toxic chemicals into the environment.
The mosquitoes targeted by the program belong primarily to the Aedes aegypti and Culex species, which are among the world’s most notorious disease vectors.
Aedes aegypti mosquitoes are known for transmitting dengue, yellow fever, chikungunya, and Zika virus, while Culex mosquitoes play a major role in spreading West Nile virus and several forms of encephalitis.
Public health experts have long warned that climate change, urbanization, and global travel are increasing the risk of mosquito-borne disease outbreaks in many regions.
Alphabet believes its technology can provide a scalable and environmentally friendly alternative to traditional mosquito control methods.
A unique aspects of Project Debug is its use of automation and artificial intelligence.
The company has developed sophisticated robotic systems capable of breeding, sorting, and preparing millions of mosquitoes for release. These systems use machine learning and computer vision technology to distinguish between male and female insects with remarkable accuracy.
The ability to automatically separate males from females is critical because only male mosquitoes are intended for release.
Alphabet says its automated technology allows scientists to rear and process insects in numbers that would be difficult to achieve through conventional methods.
The proposal now sits before the EPA, which must determine whether the project meets federal safety and environmental standards.
Alphabet has requested an Experimental Use Permit under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), a regulatory framework governing pest-control technologies in the United States.
The company must wait until the EPA completes its review process and issues a formal ruling on the permit application.
Should regulators approve the proposal, releases could begin later in 2026 and continue for two years.
